MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 28, 2006; DOI: 10.1124/mol.106.026625


0026-895X/06/7005-1494-1502$20.00
Mol Pharmacol 70:1494-1502, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026625v1
70/5/1494    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, M. M.
Right arrow Articles by Haylett, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, M. M.
Right arrow Articles by Haylett, D. G.

Enhancement of Hippocampal Pyramidal Cell Excitability by the Novel Selective Slow-Afterhyperpolarization Channel Blocker 3-(Triphenylmethylaminomethyl)pyridine (UCL2077)

Mala M. Shah, Mazyar Javadzadeh-Tabatabaie, David C. H. Benton, C. Robin Ganellin, and Dennis G. Haylett

Departments of Pharmacology (M.M.S., D.C.H.B., D.G.H.) and Chemistry (M.J.-T., C.R.G.), University College London, Gower Street, London, United Kingdom

The slow afterhyperpolarization (sAHP) in hippocampal neurons has been implicated in learning and memory. However, its precise role in cell excitability and central nervous system function has not been explicitly tested for 2 reasons: 1) there are, at present, no selective inhibitors that effectively reduce the underlying current in vivo or in intact in vitro tissue preparations, and 2) although it is known that a small conductance K+ channel that activates after a rise in [Ca2+]i underlies the sAHP, the exact molecular identity remains unknown. We show that 3-(triphenylmethylaminomethyl)pyridine (UCL2077), a novel compound, suppressed the sAHP present in hippocampal neurons in culture (IC50 = 0.5 µM) and in the slice preparation (IC50 {approx} 10 µM). UCL2077 was selective, having minimal effects on Ca2+ channels, action potentials, input resistance and the medium afterhyperpolarization. UCL2077 also had little effect on heterologously expressed small conductance Ca2+-activated K+ (SK) channels. Moreover, UCL2077 and apamin, a selective SK channel blocker, affected spike firing in hippocampal neurons in different ways. These results provide further evidence that SK channels are unlikely to underlie the sAHP. This study also demonstrates that UCL2077, the most potent, selective sAHP blocker described so far, is a useful pharmacological tool for exploring the role of sAHP channels in the regulation of cell excitability in intact tissue preparations and, potentially, in vivo.


Received May 13, 2006; accepted July 28, 2006

Address correspondence to: Mala M. Shah, Department of Pharmacology, University College London, Gower Street, London WC1E 6BT UK. E-mail: mala.shah{at}ucl.ac.uk




This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
L. Zhang, L. P. Renaud, and M. Kolaj
Properties of a T-Type Ca2+Channel-Activated Slow Afterhyperpolarization in Thalamic Paraventricular Nucleus and Other Thalamic Midline Neurons
J Neurophysiol, June 1, 2009; 101(6): 2741 - 2750.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
N. Gu, H. Hu, K. Vervaeke, and J. F. Storm
SK (KCa2) Channels Do Not Control Somatic Excitability in CA1 Pyramidal Neurons But Can Be Activated by Dendritic Excitatory Synapses and Regulate Their Impact
J Neurophysiol, November 1, 2008; 100(5): 2589 - 2604.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics